Bigul

Indo Us Bio-Tech Ltd - 541304 - Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requirement) Regulation, 2015 Read With Regulation 15 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015.

Dear Sir, Regulation 24A shall not apply, in respect of: a) the listed entity having paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty-five crore, as on the last day of the previous financial year. b) the listed entity which has listed its specified securities on the SME Exchange. Accordingly, as per exemption given under Regulation 15(2)(a) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the requirement of submission of Secretarial Compliance Report is not applicable to the Company as the paid-up Equity share capital and Net worth as on the last day of previous financial year is not exceeding Rs. 10 Crores and Rs. 25 Crores respectively and our company is listed on the SME Exchange. This is for your information and records.
08-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Shareholding for the Period Ended March 31, 2021

Indo Us Bio-Tech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
06-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances- Compliance Certificate For The Period Ended March, 2021

We hereby certify that all activities in relation to both physical and electronic share transfer facilities are maintained by our Registrar and Share Transfer Agent i.e., Bigshare Services Private Limited (SEBI Reg. No. INR000001385) having its Office at A/802, Samundra Complex, Near Klassic Gold, Girish cold drink, C.G. Road, Ahmedabad-380009, Gujarat Further, we confirm that Bigshare Services Private Limited is registered with Securities and Exchange Board of India to act as Registrar and Transfer Agents. Further, pursuant to Regulation 7(3) of the LODR Regulations, we are submitting the compliance certificate for the Half Year/ financial year ended on 31st March, 2021 i.e., for the period from October 1, 2020 to March 31, 2021. We request you to take this certificate on record.
06-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We herewith enclose a Certificate dated 2nd April, 2021 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter/year ended 31st March, 2021 received from M/s. Bigshare Services Private Limited, Registrar and Share Transfer Agent of our company. Thanking you
03-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dimpy JoshiDesignation :- Company Secretary and Compliance Officer
03-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Submission Of Annual Disclosure Under Regulation 30(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 For The Year Ended 31St March, 2021

Enclosed herewith a copy of Annual Disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for the year ended 31st March, 2021 received from Mr. Jagdishkumar Devjibhai Ajudiya Promoter of the Company on behalf of himself and other Members of Promoter & Promoter Group. Kindly take the same on your record.
03-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Submission Of Declaration Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011 On Behalf Of Promoters Of The Company

Enclosed herewith is the Declaration under Regulation 31(4) of SEBI (SAST) Regulations, 2011 received from Mr. Jagdishkumar Devjibhai Ajudiya Promoter of the Company on behalf of himself and other Members of Promoter & Promoter Group. Kindly take the same on your record.
03-04-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Closure of Trading Window

This is to inform you that in terms of Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and immediate relatives of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, read with BSE vide circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019, the Trading Window for dealing in the Securities of the Company will remain closed from Thursday, 1st April, 2021 till 48 hours after announcement / declaration of Audited financial results for the quarter and year ended 31st March, 2021. This is for your information and record.
31-03-2021
Bigul

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Change in Directorate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Para A of Part A of Schedule III to the said Regulations, we hereby inform that Ms. Nidhi Ajudia (DIN: 08607725) Non- Executive and Independent Director of the Company has, vide their letters dated 10th February, 2021, tendered her resignation as Director of the Company from the said position.
10-02-2021
Next Page
Close

Let's Open Free Demat Account